Biomatrix Healthcare Private Limited Flucloxacillin Export Data — India (DGFT 2022–2026)

Name: Biomatrix Healthcare Private Limited Flucloxacillin Export Records India — #15 Exporter, 22 Shipments, $278.0K FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-05-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Flucloxacillin

India Pharmaceutical Trade Intelligence

$38.8M123 Suppliers44 CountriesHS 30041090

ExportsIndia → UNITED KINGDOM36.4%India → AUSTRALIA14.0%

ImportsAUSTRALIA → India$10.0K UNITED KINGDOM → India$8.9K

#1 Supplier: MEDREICH LIMITED #1 Buyer: MEDREICH PLC

Biomatrix Healthcare Private Limited — Flucloxacillin Exporter #15 | $278.0K Trade Value | TransData Nexus | TransData Nexus

Biomatrix Healthcare Private Limited — Flucloxacillin Exporter Profile

Indian Pharmaceutical Exporter · #15 for Flucloxacillin · $278.0K export value · DGFT Verified

Biomatrix Healthcare Private Limited is the #15 Indian exporter of Flucloxacillin with $278.0K in export value and 22 verified shipments. Biomatrix Healthcare Private Limited holds a 0.7% market share in Flucloxacillin exports across 5 countries. The company exports 15 pharmaceutical products worth $25.7M across 6 therapeutic categories.

Biomatrix Healthcare Private Limited — Flucloxacillin Export Profile: Buyers & Destinations

Biomatrix Healthcare Private Limited Flucloxacillin export treemap — buyers and destination countries | TransData Nexus

Where Does Biomatrix Healthcare Private Limited Export Flucloxacillin?

Country	Value	Shipments	Share
CONGO	$93.5K	9	30.3%
CONGO, THE DEMOCRATIC REPUBLIC OF THE	$81.0K	9	26.3%
CONGO D REPULIC	$79.7K	3	25.8%
MOZAMBIQUE	$35.7K	2	11.6%
ANGOLA	$12.9K	1	4.2%

Who Are the Top Buyers of Flucloxacillin from Biomatrix Healthcare Private Limited?

Buyer	Country	Value	Orders
UNIQUE PHARMA,	CONGO, THE DEMOCRATIC REPUBLIC OF THE	$160.7K	12
UNIQUE PHARMA	CONGO	$68.6K	7
ACE HEALTH CARE LDA	MOZAMBIQUE	$35.7K	2
UNIQUE PHARMA STE UNION DE	CONGO	$30.4K	3
UNICA FARMA,LDA.	ANGOLA	$12.9K	1

Biomatrix Healthcare Private Limited supplies Flucloxacillin to 5 buyers globally. The largest buyer is UNIQUE PHARMA, (CONGO, THE DEMOCRATIC REPUBLIC OF THE), followed by UNIQUE PHARMA (CONGO) and ACE HEALTH CARE LDA (MOZAMBIQUE). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Flucloxacillin Formulations Does Biomatrix Healthcare Private Limited Export?

Product Description / Formulation	Value	Shipments
Flucloxacillin Capsules BP 500mg (Flux)(AS PER INV)	$47.5K	1
Flucloxacillin Capsules BP 500 mg (FLUX	$45.4K	3
Flucloxacillin Oral Solution BP 250mg /	$24.5K	3
Flucloxacillin Oral Solution BP 250mg /5ml (Flux 250) (AS PER INV)	$24.1K	1
Flucloxacillin Oral Solution BP 125mg /	$20.0K	3
Flucloxacillin Capsules BP 500 mg FLUCL	$18.0K	1
Flucloxacillin Capsules BP 500 mg (Fluclocin) (AS PER INV)	$17.8K	1
Flucloxacillin Capsules BP 500 mg FLUX	$16.3K	1
Flucloxacillin Capsules BP 500 mg FLUX 500	$16.3K	1
Flucloxacillin Capsules BP 500 mg FLUX 500 AS PER INV	$16.2K	1

Biomatrix Healthcare Private Limited exports 19 distinct Flucloxacillin formulations including tablets, capsules, syrups, and combination drugs. The top formulation is Flucloxacillin Capsules BP 500mg (Flux)(AS PER INV) with 1 shipments worth $47.5K.

How Does Biomatrix Healthcare Private Limited Compare to Nearest Flucloxacillin Exporters?

Exporters ranked immediately above and below #15 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
13	SCOTT EDIL PHARMACIA LIMITED	$320.4K	22	9	$14.6K
14	MAXHEAL PHARMACEUTICALS (INDIA) LIMITED	$314.5K	13	2	$24.2K
15	BIOMATRIX HEALTHCARE PRIVATE LIMITED ★	$278.0K	22	5	$12.6K
3	KROSYL PHARMACEUTICALS PRIVATE LIMITED	$150.0K	3	1	$50.0K

Biomatrix Healthcare Private Limited ranks #15 among 123 Indian Flucloxacillin exporters. Average shipment value of $12.6K compared to the market average of $243.5K. The closest competitors by value are SCOTT EDIL PHARMACIA LIMITED and MAXHEAL PHARMACEUTICALS (INDIA) LIMITED.

Which Indian Ports Ship Flucloxacillin Exports?

Port	Shipments	% Share
BANGALORE ICD	140	12.2%
BANGALORE ICD (INWFD6)	107	9.3%
NHAVA SHEVA SEA (INNSA1)	100	8.7%
JNPT	76	6.6%
BANGALORE ACC (INBLR4)	69	6.0%
JNPT/ NHAVA SHEVA SEA	55	4.8%
SAHAR AIR	50	4.4%
BANGALORE AIR	36	3.1%

Geopolitical & Trade Policy Impact on Biomatrix Healthcare Private Limited's Flucloxacillin Exports

The current geopolitical landscape presents both challenges and opportunities for Indian pharmaceutical exporters like Biomatrix. The Israel-Iran conflict has led to disruptions in Red Sea shipping routes, resulting in increased freight charges and extended transit times. These logistical hurdles can delay deliveries and escalate costs, particularly affecting time-sensitive pharmaceutical shipments. (pharmaceuticalcommerce.com)

Conversely, escalating US-China trade tensions have prompted the United States to seek alternative sources for pharmaceuticals, potentially benefiting Indian exporters. However, recent U.S. tariffs on imports from countries including India pose a significant challenge. These tariffs, reaching up to 50%, could impact nearly 55% of India's exports to the U.S., placing companies like Biomatrix at a competitive disadvantage due to increased costs. (apnews.com)

In the European Union, stringent regulatory frameworks such as the Falsified Medicines Directive necessitate compliance with rigorous safety and quality standards. For Biomatrix, obtaining European Market Authorization for products like Sitagliptin Tablets signifies a proactive approach to meeting these requirements, thereby facilitating smoother access to the EU market. (biomatrixhealthcare.com)

Biomatrix Healthcare Private Limited — Regulatory Compliance & Quality Standards

The global pharmaceutical industry is witnessing heightened scrutiny regarding quality and compliance. India, housing over 600 US FDA-approved manufacturing sites, faces challenges in maintaining consistent quality standards. The US FDA's increased inspections, exceeding 200 in 2023 with plans for more in 2024, underscore the critical importance of compliance. (fact.net.in)

For Biomatrix, securing approvals from regulatory bodies such as the FDA Philippines and the Iraqi Ministry of Health reflects a commitment to upholding international quality standards. These achievements not only enhance the company's reputation but also serve as a competitive advantage in the global market. (biomatrixhealthcare.com)

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Flucloxacillin shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Biomatrix Healthcare Private Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 25 individual customs records matching Biomatrix Healthcare Private Limited exporting Flucloxacillin, covering 19 formulations to 6 countries via 5 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 44+ countries, 198+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Flucloxacillin

Flucloxacillin

Biomatrix Healthcare Private Limited — Flucloxacillin Exporter Profile

Biomatrix Healthcare Private Limited — Flucloxacillin Export Profile: Buyers & Destinations

Where Does Biomatrix Healthcare Private Limited Export Flucloxacillin?

Who Are the Top Buyers of Flucloxacillin from Biomatrix Healthcare Private Limited?

What Is India's Total Flucloxacillin Export Value and How Much Does Biomatrix Healthcare Private Limited Contribute?

What Is the Average Shipment Value for Biomatrix Healthcare Private Limited's Flucloxacillin Exports?

How Does Biomatrix Healthcare Private Limited Compare to Other Indian Flucloxacillin Exporters?

What Flucloxacillin Formulations Does Biomatrix Healthcare Private Limited Export?

How Does Biomatrix Healthcare Private Limited Compare to Nearest Flucloxacillin Exporters?

Which Indian Ports Ship Flucloxacillin Exports?

What Other Advanced Antibiotics Products Does Biomatrix Healthcare Private Limited Export?

Geopolitical & Trade Policy Impact on Biomatrix Healthcare Private Limited's Flucloxacillin Exports

Biomatrix Healthcare Private Limited — Regulatory Compliance & Quality Standards

About Biomatrix Healthcare Private Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Flucloxacillin Export Data from Biomatrix Healthcare Private Limited

Flucloxacillin Stats

Company Overview

Top Products by Biomatrix Healthcare Private Limited

Related Analysis

Need Detailed Export Data?

Data Source